Literature DB >> 8686753

Epidermal growth factor receptor expression in oligodendroglial tumors.

J Reifenberger1, G Reifenberger, K Ichimura, E E Schmidt, W Wechsler, V P Collins.   

Abstract

A series of 13 oligodendrogliomas (WHO grade II) and 20 anaplastic oligodendrogliomas (WHO grade III) was studied for gene amplification and expression of the epidermal growth factor receptor gene (EGFR). EGFR gene amplification was found in only one case of anaplastic oligodendroglioma, which additionally showed a deletion/rearrangement at the 5' end of the gene. Northern blot analysis, however, revealed increases of EGFR mRNA expression relative to non-neoplastic control brain in 6 of 13 oligodendrogliomas and 10 of 18 anaplastic oligodendrogliomas. All cases with increased mRNA expression showed strong immunoreactivity for EGFR protein. Our findings thus indicate that increased expression of EGFR mRNA and protein is common in low-grade and high-grade oligodendroglial tumors and in the vast majority of cases is not caused by gene amplification.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8686753      PMCID: PMC1865223     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  34 in total

1.  Gene amplification in malignant human gliomas: clinical and histopathologic aspects.

Authors:  S H Bigner; P C Burger; A J Wong; M H Werner; S R Hamilton; L H Muhlbaier; B Vogelstein; D D Bigner
Journal:  J Neuropathol Exp Neurol       Date:  1988-05       Impact factor: 3.685

2.  The epidermal growth factor receptor gene and its product.

Authors:  T Hunter
Journal:  Nature       Date:  1984 Oct 4-10       Impact factor: 49.962

3.  Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin.

Authors:  T A Libermann; H R Nusbaum; N Razon; R Kris; I Lax; H Soreq; N Whittle; M D Waterfield; A Ullrich; J Schlessinger
Journal:  Nature       Date:  1985 Jan 10-18       Impact factor: 49.962

4.  Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells.

Authors:  A Ullrich; L Coussens; J S Hayflick; T J Dull; A Gray; A W Tam; J Lee; Y Yarden; T A Libermann; J Schlessinger
Journal:  Nature       Date:  1984 May 31-Jun 6       Impact factor: 49.962

5.  Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification.

Authors:  A J Wong; S H Bigner; D D Bigner; K W Kinzler; S R Hamilton; B Vogelstein
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

6.  Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p.

Authors:  J Reifenberger; G Reifenberger; L Liu; C D James; W Wechsler; V P Collins
Journal:  Am J Pathol       Date:  1994-11       Impact factor: 4.307

7.  Overexpression of the human EGF receptor confers an EGF-dependent transformed phenotype to NIH 3T3 cells.

Authors:  P P Di Fiore; J H Pierce; T P Fleming; R Hazan; A Ullrich; C R King; J Schlessinger; S A Aaronson
Journal:  Cell       Date:  1987-12-24       Impact factor: 41.582

8.  Induction of epidermal growth factor receptor gene transcription by transforming growth factor beta 1: association with loss of protein binding to a negative regulatory element.

Authors:  X Hou; A C Johnson; M R Rosner
Journal:  Cell Growth Differ       Date:  1994-08

9.  Selective amplification of the cytoplasmic domain of the epidermal growth factor receptor gene in glioblastoma multiforme.

Authors:  L T Malden; U Novak; A H Kaye; A W Burgess
Journal:  Cancer Res       Date:  1988-05-15       Impact factor: 12.701

10.  Allelic loss at 1p and 19q frequently occurs in association and may represent early oncogenic events in oligodendroglial tumors.

Authors:  M J Bello; P E Leone; J Vaquero; J M de Campos; M E Kusak; J L Sarasa; A Pestaña; J A Rey
Journal:  Int J Cancer       Date:  1995-06-22       Impact factor: 7.396

View more
  17 in total

1.  EGFR expression stratifies oligodendroglioma behavior.

Authors:  Craig Horbinski; Jonathan Hobbs; Kathleen Cieply; Sanja Dacic; Ronald L Hamilton
Journal:  Am J Pathol       Date:  2011-08-11       Impact factor: 4.307

2.  Cells with intense EGFR staining and a high nuclear to cytoplasmic ratio are specific for infiltrative glioma: a useful marker in neuropathological practice.

Authors:  Fanny Burel-Vandenbos; Laurent Turchi; Maxime Benchetrit; Eric Fontas; Zoe Pedeutour; Valérie Rigau; Fabien Almairac; Damien Ambrosetti; Jean-François Michiels; Thierry Virolle
Journal:  Neuro Oncol       Date:  2013-08-09       Impact factor: 12.300

3.  EGFR promoter exhibits dynamic histone modifications and binding of ASH2L and P300 in human germinal matrix and gliomas.

Authors:  Parsa Erfani; Jessica Tome-Garcia; Peter Canoll; Fiona Doetsch; Nadejda M Tsankova
Journal:  Epigenetics       Date:  2015-05-21       Impact factor: 4.528

Review 4.  EGFR-dependent mechanisms in glioblastoma: towards a better therapeutic strategy.

Authors:  Cristina Zahonero; Pilar Sánchez-Gómez
Journal:  Cell Mol Life Sci       Date:  2014-03-27       Impact factor: 9.261

5.  EGFR immunolabeling pattern may discriminate low-grade gliomas from gliosis.

Authors:  Fanny Burel-Vandenbos; Maxime Benchetrit; Catherine Miquel; Denys Fontaine; Romane Auvergne; Christine Lebrun-Frenay; Nathalie Cardot-Leccia; Jean-François Michiels; Veronique Paquis-Flucklinger; Thierry Virolle
Journal:  J Neurooncol       Date:  2010-07-24       Impact factor: 4.130

6.  Spontaneous canine gliomas: overexpression of EGFR, PDGFRalpha and IGFBP2 demonstrated by tissue microarray immunophenotyping.

Authors:  Robert J Higgins; Peter J Dickinson; Richard A LeCouteur; Andrew W Bollen; Huamin Wang; Hua Wang; Linda J Corely; Lynnette M Moore; Wei Zang; Gregory N Fuller
Journal:  J Neurooncol       Date:  2009-12-05       Impact factor: 4.130

Review 7.  Pathology and molecular genetics of oligodendroglial tumors.

Authors:  Christian Hartmann; Wolf Mueller; Andreas von Deimling
Journal:  J Mol Med (Berl)       Date:  2004-10       Impact factor: 4.599

8.  Targeted therapy in the treatment of malignant gliomas.

Authors:  Rimas V Lukas; Adrienne Boire; M Kelly Nicholas
Journal:  Onco Targets Ther       Date:  2009-02-18       Impact factor: 4.147

9.  Chromosomal Aberrations in Canine Gliomas Define Candidate Genes and Common Pathways in Dogs and Humans.

Authors:  Peter J Dickinson; Dan York; Robert J Higgins; Richard A LeCouteur; Nikhil Joshi; Danika Bannasch
Journal:  J Neuropathol Exp Neurol       Date:  2016-05-31       Impact factor: 3.685

Review 10.  Immunological considerations of modern animal models of malignant primary brain tumors.

Authors:  Michael E Sughrue; Isaac Yang; Ari J Kane; Martin J Rutkowski; Shanna Fang; C David James; Andrew T Parsa
Journal:  J Transl Med       Date:  2009-10-08       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.